Product
CpG 1018/Alum-adjuvanted SCB-2019
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Double-Blind, Randomized, Controlled, Phase 3 Study to Evaluate the Safety and Immunogenicity of CpG 1018/Alum-adjuvanted SCB-2019 in Individuals Aged 18 and Above With Chronic Immune-Mediated Inflammatory DiseasesStatus: Terminated, Estimated PCD: 2022-03-30